Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Aug 18;5(3):27.
doi: 10.3390/antiox5030027.

Cranberries and Cancer: An Update of Preclinical Studies Evaluating the Cancer Inhibitory Potential of Cranberry and Cranberry Derived Constituents

Affiliations
Review

Cranberries and Cancer: An Update of Preclinical Studies Evaluating the Cancer Inhibitory Potential of Cranberry and Cranberry Derived Constituents

Katherine M Weh et al. Antioxidants (Basel). .

Abstract

Cranberries are rich in bioactive constituents reported to influence a variety of health benefits, ranging from improved immune function and decreased infections to reduced cardiovascular disease and more recently cancer inhibition. A review of cranberry research targeting cancer revealed positive effects of cranberries or cranberry derived constituents against 17 different cancers utilizing a variety of in vitro techniques, whereas in vivo studies supported the inhibitory action of cranberries toward cancers of the esophagus, stomach, colon, bladder, prostate, glioblastoma and lymphoma. Mechanisms of cranberry-linked cancer inhibition include cellular death induction via apoptosis, necrosis and autophagy; reduction of cellular proliferation; alterations in reactive oxygen species; and modification of cytokine and signal transduction pathways. Given the emerging positive preclinical effects of cranberries, future clinical directions targeting cancer or premalignancy in high risk cohorts should be considered.

Keywords: cancer; cranberry; proanthocyanidin; quercetin; ursolic acid.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Cranberry and cranberry derived constituents target numerous mechanisms of cancer inhibition based on 34 preclinical studies.

References

    1. Blumberg J.B., Camesano T.A., Cassidy A., Kris-Etherton P., Howell A., Manach C., Ostertag L.M., Sies H., Skulas-Ray A., Vita J.A. Cranberries and their bioactive constituents in human health. Adv. Nutr. 2013;4:618–632. doi: 10.3945/an.113.004473. - DOI - PMC - PubMed
    1. Neto C.C. Cranberry and blueberry: Evidence for protective effects against cancer and vascular diseases. Mol. Nutr. Food Res. 2007;51:652–664. doi: 10.1002/mnfr.200600279. - DOI - PubMed
    1. Nantz M.P., Rowe C.A., Muller C., Creasy R., Colee J., Khoo C., Percival S.S. Consumption of cranberry polyphenols enhances human gamma delta-T cell proliferation and reduces the number of symptoms associated with colds and influenza: A randomized, placebo-controlled intervention study. Nutr. J. 2013;12:161. doi: 10.1186/1475-2891-12-161. - DOI - PMC - PubMed
    1. Steinberg D., Feldman M., Ofek I., Weiss E.I. Cranberry high molecular weight constituents promote streptococcus sobrinus desorption from artificial biofilm. Int. J. Antimicrob. Agents. 2005;25:247–251. doi: 10.1016/j.ijantimicag.2004.10.014. - DOI - PubMed
    1. Howell A.B., Foxman B. Cranberry juice and adhesion of antibiotic-resistant uropathogens. JAMA. 2002;287:3082–3083. doi: 10.1001/jama.287.23.3077. - DOI - PubMed